Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum China Health Labs & Diagnostics Ltd CHLBF

GREY:CHLBF - Post Discussion

China Health Labs & Diagnostics Ltd > CHO receives a go private takeover offer.
View:
Post by lscfa on Oct 24, 2013 12:44pm

CHO receives a go private takeover offer.

Although the offer is for $0.62 , a 44% premium over yesterday's stock price, it is too low. I am voting against the offer. This stock is worth a lot more.
Comment by VPofFNE on Oct 24, 2013 12:55pm
Are you nuts?!?! 18 months of suffering below $0.60. I'm voting yes....185 thousand times.... VeeP
Comment by lscfa on Oct 24, 2013 1:06pm
Fundamental Research Corp. issued a research report on  February 22, 2012 when the stock was at $0.48. They rated the stock a buy with a fair value of $2.16 
Comment by VPofFNE on Oct 25, 2013 10:35am
And yet 20 months later we toiled below $0.40. China Health....like many other Chinese companies in the post Sino Forest era....trades poorly in North America. This company needs to be taken private while they acheive their growth plans and deal with their unbelievably high A/R. Once this is done, they should look to go public in HK or Singapore. VeeP
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities